European and United States scientists have joined forces to develop a male contraceptive pill.
The deal was struck between a Norwegian biotech company and the University of Massachusetts Medical School and revolves around research to develop a drug that blocks sperm's ability to swim and fertilise an egg.
The method targets a protein only found in sperm cells, called Cs, which requires sophisticated chemical screening.
AdvertisementAdvertise with NZME.
Latest from Technology
How soon will machines outsmart humans? The biggest brains in AI disagree
Financial Times: Elon Musk's prediction sets him apart from his rivals.